PrecisCa celebrates it's 2026 Distinguished Faculty & Oncology Fellows Forum East, Miami, FL

Expert Cancer Panel: Metastatic thymoma w/ partial response from front-line combination chemotherapy

Expert Cancer Panel: Stage 3 thymic carcinoma presenting for determination of front-line therapy

Expert Cancer Panel: Metastatic epithelioid mesothelioma w/ progression on first-line chemotherapy

Expert Cancer Panel: EGFR+ lung adenocarcinoma, on osimertinib but stopped due to pneumonitis

Expert Cancer Panel: pT1bN0M0 SCC of RLL s/p lobectomy with local recurrence with no mets; PD-L1 70%

Expert Cancer Panel: Stage IV SCC of lung s/p chemo, RT and IO with widespread disease; PD-L1 40%

Expert Cancer Panel: Stage II adenosquamous carcinoma s/p resection with positive margins

Expert Cancer Panel: Unresectable lung neuroendocrine tumor with progression after octreotide and RT

Expert Cancer Panel: Stage III atypical carcinoid of mediastinum resected w/ clear margins

Expert Cancer Panel: Stage IV lung adenocarcinoma, PD-L1 greater than 50%, with SD

Expert Cancer Panel: Stage IV lung cancer with EGFR exon 19 del, progressed on several treatments

Expert Cancer Panel: Stage IV SCC of the lung, PD-L1 negative, with painful lymphadenopathy

Expert Cancer Panel: Limited stage SCLC with localized nodal recurrence after chemoradiation

Expert Cancer Panel: Stage II lung adenocarcinoma treated with chemoradiation with recurrent disease

Expert Cancer Panel: WHO type B1 thymoma with positive margins following resection

Expert Cancer Panel: Stage IIIC superior sulcus tumor w/ extension to rib and PET-avid supraclav LN

Expert Cancer Panel: Stage II EGFR mutant NSCLC s/p neoadjuvant chemo/RT/surgery with new RUL nodule

Expert Cancer Panel: Newly diagnosed stage IV lung adenocarcinoma, EGFR mutation positive

Expert Cancer Panel: Recurrent adenocarcinoma s/p pneumectomy, RT and SBRT, currently on osimertinib

Expert Cancer Panel: Stage IVA lung cancer, PD-L1+, KRAS G12C, with single brain met s/p craniotomy

Expert Cancer Panel: Stage IIB adenosquamous carcinoma w/ mets to ribs following definitive therapy

Expert Cancer Panel: Recurrent lung adenocarcinoma positive for MET exon 14 mutation s/p surgery

Expert Cancer Panel: Lung adenocarcinoma s/p NAC and surgery w/ final pathology ypT1aN2M0

Expert Cancer Panel: Front-line management of clinical stage I NSCLC

Expert Cancer Panel: Stage IIB lung adenocarcinoma presenting for adjuvant therapy s/p lobectomy

Expert Cancer Panel: Stage IVA neuroendocrine lung carcinoma s/p bi-lobectomy

Expert Cancer Panel: Extensive stage SCLC w/ SVC syndrome and brain metastases

Expert Cancer Panel: Stage IIA thymoma s/p surgery w/ close margins & microscopic capsular invasion

Expert Cancer Panel: Completely resected stage IIIA SCLC, initially staged as adenocarcinoma

Expert Cancer Panel: Stage IIA superior sulcus tumor (PD-L1 2%) w/ PET-avid LNs negative on EBUS

Expert Cancer Panel: Stage IV LUL adenosquamous; ALK neg, PD-L1 greater than 1%

Expert Cancer Panel: EGFR-mutated adenocarcinoma of the lung w/ cord compression and bone mets

Expert Cancer Panel: mNSCLC, ALK+, w/ CNS progression and controlled systemic disease on alectinib

Expert Cancer Panel: Stage IV lung cancer w/ progression s/p carboplatin/pemetrexed/pembrolizumab

Expert Cancer Panel: Stage IVB lung cancer (RET+/PD-L1 50%) w/ seizures from innumerable brain mets

Expert Cancer Panel: Relapsed, non-secretory multiple myeloma

Expert Cancer Panel: Relapsed/refractory multiple myeloma with t(11;14) translocation

Expert Cancer Panel: IgA Kappa MM with R/R disease after multiple treatments and CAR-T

Expert Cancer Panel: Multiple myeloma w/ extramedullary plasmacytoma with plasmablastic features

Expert Cancer Panel: Newly diagnosed monoclonal gammopathy of renal significance

Expert Cancer Panel: Relapsed T-cell / Histiocyte rich B-cell Lymphoma (THRLBCL)

Expert Cancer Panel: Newly diagnosed CD30 negative peripheral T-cell lymphoma and HLH

Expert Cancer Panel: Relapsed, refractory CLL with del(17p)/TP53 mutation

Expert Cancer Panel: CML chronic phase T315I mutated s/p multiple lines of therapy

Expert Cancer Panel: Relapsed AML in the leptomeningeal and parenchymal CNS

Expert Cancer Panel: Rapidly progressive diffuse lymphadenopathy w/ biopsy-proven T-cell ALL

Expert Cancer Panel: High-risk MDS w/ excess blasts-2 diagnostics and management

Expert Cancer Panel: Mantle cell lymphoma relapsed after ASCT

Expert Cancer Panel: Relapsed/refractory follicular lymphoma

Expert Cancer Panel: Relapsed double-hit lymphoma involving the CNS

Expert Cancer Panel: Workup and management of relapsed and extranodal diffuse large B-cell lymphoma

Expert Cancer Panel: Newly diagnosed advanced stage classical Hodgkin’s lymphoma

Expert Cancer Panel: Transplant-eligible male with extensive relapsed classical Hodgkin lymphoma

Expert Cancer Panel: IgA Kappa multiple myeloma s/p auto SCT on lenalidomide maintenance w/ relapse

Expert Cancer Panel: Jehovah’s witness w/ multiple myeloma s/p RVD under evaluation for auto SCT

Expert Cancer Panel: Relapsed stage III multiple myeloma develops neutropenia with lenalidomide

Expert Cancer Panel: Multiple myeloma with high-risk cytogenetics and extramedullary involvement

Expert Cancer Panel: MM in remission and ESRD requiring HD undergoing eval for renal transplant

Expert Cancer Panel: Multiple myeloma on maintenance lenalidomide develops pulmonary embolism